Mylin Biotech India Private Limited, a active private limited company, was established on 10 December 2012 in Bangalore North, Karnataka, India. Engaging in preventive health services within the trade sector, it holds CIN: U73100KA2012PTC067115. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.34 M.
It upholds a compliant status. Employing 15 professional, Its leadership includes Kavitha Prabakaran (Director), Ramasamy Ramajayam Pillai (Director), Pandurangan Prabhakran (Director). Past directors included Pandurangan Prabhakran. It holds ₹3.58 Cr open charges and ₹3.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at #254/1-9, 11Th Main Road, 3Rd Phase, Peenya, Bangalore, Karnataka- 560058, Bangalore North, Karnataka, 560058.
U73100KA2012PTC067115
067115
10 December 2012
₹0.50 M
₹0.34 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Mylin Biotech India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kavitha Prabakaran | Director | 10 Dec 2012 | Current |
| Ramasamy Ramajayam Pillai | Director | 10 Dec 2012 | Current |
| Pandurangan Prabhakran | Director | 09 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mylin Biotech India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.95% increase. The company also saw a substantial fall in profitability, with a 263.17% decrease in profit. The company's net worth Soared by an impressive increase of 154.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mylin Biotech India had a public holding of 70.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹35,800,000.00
₹3,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Apr 2022 | State Bank Of India | ₹3.26 Cr | Open |
| 09 Dec 2020 | Hdfc Bank Limited | ₹3.20 M | Open |
| 20 May 2021 | Hdfc Bank Limited | ₹3.50 M | Satisfied |
Explore comprehensive loan charge details -
Mylin Biotech India has a workforce of 15 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mylin Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mylin Biotech India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Mylin Biotech India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Mylin Biotech India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
The activity A charge with State Bank Of India of Rs. 32.60 M registered on 19 Apr 2022 with Charge ID 100569454 was modified on 09 Nov 2023. was completed.
The activity A charge registered on 20 May 2021 via Charge ID 100447909 with Hdfc Bank Limited was fully satisfied on 11 May 2022. was completed.
The activity Pandurangan Prabhakran was appointed as a Director was appointed as a Director on 09 May 2022 & has been associated with this company since 3 years 7 months . was completed.
The activity A charge with State Bank Of India amounted to Rs. 32.60 M with Charge ID 100569454 was registered on 19 Apr 2022. was completed.
The CIN of Mylin Biotech India Private Limited is U73100KA2012PTC067115.
Mylin Biotech India Private Limited is headquartered at #254/1-9, 11Th Main Road, 3Rd Phase, Peenya, Bangalore, Karnataka- 560058, Bangalore North, Karnataka, 560058.
Mylin Biotech India Private Limited was incorporated on 10 December 2012.
The current directors of Mylin Biotech India Private Limited are
The primary industry of Mylin Biotech India Private Limited is Trade.
Mylin Biotech India Private Limited is unlisted.
The authorized capital of Mylin Biotech India Private Limited is ₹0.50 M, and the paid-up capital is ₹0.34 M.
The compliance status of Mylin Biotech India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX